Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score

PURPOSE: Although the incidence of distant relapse is decreasing, 20–30% of patients with early breast cancer die of metastasis. The aim of this study is to characterize patients with metastasis-free survival(MFS) less than 5 years, to analyze the most probable site of metastases according to the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebner, Florian, Salmen, Jessica, Dayan, Davut, Kiesel, Matthias, Wolters, Regine, Janni, Wolfgang, Wöckel, Achim, Wischnewsky, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147811/
https://www.ncbi.nlm.nih.gov/pubmed/36917303
http://dx.doi.org/10.1007/s10549-023-06898-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147811/
https://www.ncbi.nlm.nih.gov/pubmed/36917303
http://dx.doi.org/10.1007/s10549-023-06898-z

Ejemplares similares